Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

First Rand Foundation contributes funding towards students with disabilities
2017-01-02

 Description: First Rand Foundation Tags: First Rand Foundation

Photo: iStock

Bursary funding for eight students with disabilities at the University of the Free State was recently approved by the First Rand Foundation. The grant of R2 497 440 will be paid over three years: R800 000 (2016/17), R824 000 (2017/18), and R873 440 (2018/19).

This grant from the First Rand Tertiary Education Fund is a result of the negotiations between the UFS Office for Institutional Advancement and the First Rand Foundation (FRF).

Qualifying students with disabilities will be encouraged to apply for bursaries according to criteria and requirements set by the First Rand Foundation. The selection process will be handled by a panel from the UFS. The Centre for Universal Access and Disability Support (CUADS) at the UFS will be instrumental in the process of identifying students with disabilities who meet the criteria and requirements for funding.

CUADS already have a system in place to support students with disabilities in their studies and during exams. Students also have access to specialised exam and test venues for alternative test and exam procedures, as well as computer facilities.

Specialised support services include an amanuensis (scribe) service during tests and exams, accommodating extra time, individual tutor sessions provided in collaboration with the Centre for Teaching and Learning, South African Sign Language interpreter coordination, provision of accessible study material, and individual disability support.

 

“The centre aims to ensure that the university increasingly becomes a universally accessible environment that is welcoming and accepting to people with diverse abilities.”

According to Martie Miranda, Head of CUADS, the centre aims to ensure that the university increasingly becomes a universally accessible environment that is welcoming and accepting to people with diverse abilities. “Therefore disability awareness training and advocacy within the UFS, and specifically among staff members, is one of our priorities,” she said.

According to Thandeka Rantsi from the FRF, the company will furthermore support students in CUADS with regards to the needs ensuing from the #feesmustfall protests. “Exactly R34 000 was approved by the FRF for 14 students towards residence and meal expenses, as well as scribe and reader assistance during additional assessments,” she said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept